Comment on: Favipiravir, an antiviral for COVID-19?

被引：2
|
作者：
Chachaima-Mar, Jorge [1 ,2 ]
Perez-Castilla, Jesus [3 ]
机构：
[1] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru
[2] REDECS, Red Eficacia Clin & Sanitaria, Lima, Peru
[3] Natl Univ St Anthony Abbot Cusco, Sch Med, Cuzco, Peru
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2021年 / 76卷 / 01期
关键词：
D O I：
10.1093/jac/dkaa378
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：279 / 280
页数：3
相关论文
共 50 条
  • [21] Development and Validation of HPLC-DAD Method for the Determination of Favipiravir and Studying the Impact of Vitamin C on the Pharmacokinetics of COVID-19 Antiviral Drug Favipiravir
    Hailat, Mohammad
    Al-Ani, Israa
    Zakareia, Zainab
    Al-Shdefat, Ramadan
    Al-Meanazel, Osaid
    Anwer, Md Khalid
    Hamad, Mohammed
    Abu Rayyan, Walid
    Awad, Riad
    Abu Dayyih, Wael
    SEPARATIONS, 2022, 9 (10)
  • [22] Antiviral treatment of COVID-19
    Simsek Yavuz, Serap
    Unal, Serhat
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 : 611 - 619
  • [23] Antiviral Therapy of COVID-19
    Gudima, Georgii
    Kofiadi, Ilya
    Shilovskiy, Igor
    Kudlay, Dmitry
    Khaitov, Musa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [24] An antiviral drug for covid-19?
    Benestad, Haakon B.
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (12) : 1176 - 1176
  • [25] Effectiveness of favipiravir in COVID-19: a live systematic review
    Ozlusen, Batu
    Kozan, Sima
    Akcan, Rustu Emre
    Kalender, Mekselina
    Yaprak, Dogukan
    Peltek, Ibrahim Batuhan
    Keske, Siran
    Gonen, Mehmet
    Ergonul, Onder
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (12) : 2575 - 2583
  • [26] Effectiveness of favipiravir in COVID-19: a live systematic review
    Batu Özlüşen
    Şima Kozan
    Rüştü Emre Akcan
    Mekselina Kalender
    Doğukan Yaprak
    İbrahim Batuhan Peltek
    Şiran Keske
    Mehmet Gönen
    Önder Ergönül
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 2575 - 2583
  • [27] Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID-19
    Irie, Kei
    Nakagawa, Atsushi
    Fujita, Hirotoshi
    Tamura, Ryo
    Eto, Masaaki
    Ikesue, Hiroaki
    Muroi, Nobuyuki
    Tomii, Keisuke
    Hashida, Tohru
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05): : 880 - 885
  • [28] An AGEP case due to COVID-19 or favipiravir or enoxaparin
    Daye, Munise
    Oltulu, Pembe
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (01) : 13 - 15
  • [29] A Favipiravir-induced Fever in a Patient with COVID-19
    Kurita, Takashi
    Ishida, Keiko
    Muranaka, Emiri
    Sasazawa, Hiroki
    Mito, Haruki
    Yano, Yudai
    Hase, Ryota
    INTERNAL MEDICINE, 2020, 59 (22) : 2951 - 2953
  • [30] PIONEER trial: favipiravir to treat moderate COVID-19
    Shalhoub, Sarah
    LANCET RESPIRATORY MEDICINE, 2023, 11 (05): : 392 - 393
12345